-
PurposeLentiviral plasmid for expression of gRNA and dCas9 in mammalian cells; derivative of lentiCRISPR v2
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 112233 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneCustom
- Backbone size w/o insert (bp) 10000
- Total vector size (bp) 14873
-
Vector typeMammalian Expression, Lentiviral, CRISPR
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable
-
Growth instructionsOnly amplify in RecA- bacteria
-
Copy numberHigh Copy
Gene/Insert 1
-
Gene/Insert namedCas9
-
SpeciesSynthetic
-
Insert Size (bp)4200
-
MutationChanged: Aspartic acid 10 to Glycine, Histidine 840 to Alanine
- Promoter EFS-NS
-
Tag
/ Fusion Protein
- FLAG (C terminal on insert)
Cloning Information for Gene/Insert 1
- Cloning method Restriction Enzyme
- 5′ cloning site AgeI, XbaI, AfeI (not destroyed)
- 3′ cloning site BamHI (not destroyed)
- 5′ sequencing primer hEF1aprom-F
- 3′ sequencing primer WPRE-R (Common Sequencing Primers)
Gene/Insert 2
-
Gene/Insert namePorumycin resistance
-
Alt namepuromycin N-acetyl-transferase
-
Alt namePAC
-
Insert Size (bp)600
- Promoter EFS-NS
Cloning Information for Gene/Insert 2
- Cloning method Restriction Enzyme
- 5′ cloning site BanHI (not destroyed)
- 3′ cloning site MluI (not destroyed)
- 5′ sequencing primer Puro-F2
- 3′ sequencing primer WPRE-R (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byaddgene
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Plasmid is a derivative of Addgene Plasmid #52961, where the Cas9 gene has been mutated at codons 10 and 840 to create a catalytically inactive version of Cas9 (dCas9).
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
lentiCRISPR v2-dCas9 was a gift from Thomas Gilmore (Addgene plasmid # 112233 ; http://n2t.net/addgene:112233 ; RRID:Addgene_112233) -
For your References section:
CRISPR/Cas9-based editing of a sensitive transcriptional regulatory element to achieve cell type-specific knockdown of the NEMO scaffold protein. Babaei M, Liu Y, Wuerzberger-Davis SM, McCaslin EZ, DiRusso CJ, Yeo AT, Kagermazova L, Miyamoto S, Gilmore TD. PLoS One. 2019 Sep 25;14(9):e0222588. doi: 10.1371/journal.pone.0222588. eCollection 2019. 10.1371/journal.pone.0222588 PubMed 31553754